by reuter.com
https://ift.tt/pnED7n
(Reuters) - GW Pharmaceuticals Plc's epilepsy treatment on Monday secured an approval from the U.S. Food and Drug Administration, becoming the first cannabis-based drug to be approved in the country.
This is a short description in the author block about the author. You edit it by entering text in the "Biographical Info" field in the user admin panel.
0 comments:
Post a Comment